AbbVie Articles
Strong 1st-qtr for AbbVie, as Humira continues to grow
28 April 2013
Highlights of presentations from Bristol-Myers, J&J, Gilead and AbbVie at EASL meeting
24 April 2013
US gastroenterologists increasingly using biologics to treat Crohn's patients in remission
6 March 2013
FDA accepts file for new Actemra formulation in rheumatoid arthritis
28 February 2013
Positive Ph III results for AbbVie's Humira in pediatric Crohn's disease; five leukemia studies suspended
17 February 2013
Abbott board prepares way for AbbVie split off
29 November 2012
Showing 1-19 of 19 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
